By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Diagnostic solutions208.62M39.17%
Sample technologies170.11M31.94%
Polymerase Chain Reaction (PCR) / Nucleic acid amplification75.33M14.14%
Genomics / Next-Generation Sequencing (NGS)60.85M11.43%
Other17.67M3.32%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States942.01M47.62%
Europe, Middle East and Africa627.59M31.73%
Asia Pacific, Japan and Rest of World298.15M15.07%
Other Americas89.56M4.53%
Netherlands20.9M1.06%